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A B S T R A C T
Purpose: To present the clinical proﬁles and inheritance patterns of familial childhood epilepsy in the
highly consanguineous population of Jordan.
Methods: This retrospective study examined children diagnosed with epilepsy and having at least one
epileptic parent or sibling. The epilepsy type was classiﬁed according to the criteria of the International
League Against Epilepsy. Patients were monitored for a period of 6 months to 5 years.
Results: The study population included 39 children belonging to 31 families; 21 boys (53.8%) and 18 girls
(46.2%). The age at onset ranged from one month to 16 years. Generalized seizures were observed in 23
patients (58.9%), partial seizures in 14 patients (35.8%); and generalized and partial seizures in two
patients (5.1%). Seizure control was achieved in 33 patients (84.6%), and 13 patients (33.3%) were
seizure-free for at least two years. Withdrawal of antiepileptic medication was successful in ﬁve of these
13 patients (38.5%), while seizures recurred in the other eight (61.5%) on withdrawal. The consanguinity
rate among parents of affected children was 61.3%. Pedigree analysis suggested probable autosomal
dominant (AD) inheritance with or without reduced penetrance in 13 families (41.9%), probable
autosomal recessive (AR) inheritance in 6 families (19.4%), and an X-linked recessive inheritance (XR) in
one family.
Conclusions: This is the ﬁrst report on familial epilepsy involving ﬁrst degree relatives in Jordan. Genetic
testing including exome sequencing could help in reaching the accurate diagnosis and may also reveal
novel autosomal recessive genes associated with pediatric idiopathic epilepsy.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Consanguineous marriages comprise 20–40% of all marriages in
Jordan1–4 which may predispose offspring to rare autosomal
recessive conditions.5–7 Previous studies have indicated that
consanguineous marriage is a major risk factor contributing to
epilepsy in the neonatal and infancy periods.8,9
Genes implicated in idiopathic epilepsies include the SCN1A
gene, encoding the voltage-gated Na channel a1 subunit (Nav1.1),
in some autosomal dominant epilepsies (prolonged, myoclonic,
and absence seizures)10 and the TBC1D24 gene, encoding an AFR6-
interacting protein, in autosomal recessive idiopathic epilepsy.11
While the Jordanian population has a high rate of consanguineous
marriages, to our knowledge there have been no reports describing
the inheritance patterns of familial epilepsy.
This study aims to describe the inheritance patterns, clinical
proﬁles, treatment responses, and prognoses of epileptic children
with a positive history of epilepsy in their ﬁrst degree relatives.* Corresponding author. Tel.: +96 2777770919; fax: +96 25332477.
E-mail address: masriamira69@hotmail.com (A. Masri).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.02.0172. Patients and methods
This retrospective study was conducted at a child neurology
clinic at Jordan University Hospital, a tertiary care referral hospital
located in Amman, over a 10 years period from January 2001 to
August 2010.
All children aged one month to 18 years presenting with
epilepsy during the study period and with a positive family
history of epilepsy in at least one ﬁrst degree relative were
included in this study. Identiﬁcation of these patients was
possible through a personal data base of the ﬁrst author that
includes all patients presenting to the child neurology clinic
since January 2001. Files for all patients that were identiﬁed as
epileptic and having a positive family history of epilepsy were
revised. To fulﬁll the inclusion criteria, the pedigrees documen-
ted in the ﬁles were revised. In the child neurology clinic, family
history is usually obtained by the child neurologist from the
parent accompanying the child (father, mother or both) with
pedigree constructed and stored in the ﬁle. Because of the high
stigma of epilepsy in Jordan, it is common practice to rely on the
parents’ reports, without going further and interviewing other
family members such as grandmothers or grandfathers whovier Ltd. All rights reserved.
A. Masri, H. Hamamy / Seizure 22 (2013) 443–451444probably know more details about the family history. Patients
for whom a parent was not available due to death, divorce or
other reasons leading to inability to take full family history and
difﬁculty in constructing a pedigree were excluded from the
study. Postulation of mode of inheritance of epilepsy was based
on the family pedigree that was documented in the ﬁle since
genetic studies were not done for the families. Due to theFig. 1. Pedigrees of retrospective nature of the study, it was not possible to recontact
seven families who show pedigrees with data for only two
generations (Fig. 1). Children with a family history of febrile
convulsions only, a family history of epilepsy but not in ﬁrst
degree relatives, or a family history of epilepsy due to
neurodegenerative or neurometabolic disorders or due to
symptomatic epilepsy were excluded.the 31 families.
A. Masri, H. Hamamy / Seizure 22 (2013) 443–451 445In addition to the family pedigree, ﬁles were also reviewed to
collect data on the age of onset of seizure, type of seizures, type of
treatment, control of epilepsy, follow up period, neurological
examination ﬁndings, developmental history and or school
performance before and after the seizures, results of neuroimaging
and EEG ﬁndings. Files lacked information on details of the
epilepsy in the affected family members and their data were not
included in this study.
3. Deﬁnitions
The deﬁnition and classiﬁcation of seizures and epilepsies were
based on criteria set by the International League Against
Epilepsy.12 For the purposes of this study, we deﬁned controlled
epilepsy as no seizures for at least four months. Although this is not
a widely accepted criterion, it is a good indicator of seizure control
and allowed the inclusion of more patients in the study who
satisﬁed the inclusion criteria. Global developmental delay was
deﬁned as a signiﬁcant delay in two or more developmental
domains (gross/ﬁne motor, cognition, speech/language, personal/
social, or activities of daily living).13 In clinical genetics, a
consanguineous marriage usually describes a union between
second cousins or closer relatives. This deﬁnition was applied in
the present study and is equivalent to a coefﬁcient of inbreeding in
the progeny of F  0.0156. This would include the categories of ﬁrst
cousins (including double ﬁrst cousins), ﬁrst cousins once
removed, and second cousins.14
The ethical committee at Jordan University Hospital approved
this study.
4. Results
The study population included 39 children with pediatric
epilepsy belonging to 31 families and satisfying the inclusion
criteria of the study. All 39 patients attended the pediatric
neurology clinic over the study period and were examined,
managed and followed up by a child neurologist. There were 21
boys (53.8%) and 18 girls (46.2%) in the study group. The age of
seizure onset ranged from one month to 16 years, with the ﬁrst
seizure occurring at or before age ten in 31 patients (79%), and
before age six in 19 patients (49%). Twenty-three patients (59%)
were treated at our clinic within one year of disease onset.
Twenty three patients (58.9%) had generalized epilepsy, 14
patients (35.8%) had partial epilepsy and two patients (5.1%) had
both generalized and partial epilepsy. The most common type of
generalized epilepsy was generalized tonic–clonic seizures,
observed in 13 patients (33.3%). The most common partial epilepsy
was partial complex seizures, observed in 13 patients (33.3%)
(Table 1). Only two patients (5.1%) had experienced status
epilepticus.Table 1
Types of seizures in 39 patients.
Type of seizure Number of patients (%)
Generalized seizures 23(58.9%)
Generalized tonic–clonic seizures 13 (33.3%)
Absence seizures 8 (20.5%)
Myoclonic seizures 1 (2.6%)
Spasms 1 (2.6%)
Partial seizures 14 (35.8%)
Simple partial seizures 1 (2.5%)
Partial complex seizures 13(33.3%)
Generalized and partial 2 (5.1%)
Absence + partial complex epilepsy 2 (5.1%)Syndromic classiﬁcation was possible in only 9 patients (23%); 8
patients presented with absence epilepsy and one patient
presented with West syndrome; the rest of patients remained
unclassiﬁed.
Twenty nine patients (74.4%) were on monotherapy, ﬁve
(12.8%) were on two antiepileptic medications, and ﬁve (12.8%)
were on three antiepileptic medications. Seizure control was
achieved in 33 patients (84.6%) using mono- or polytherapy. The
other six patients (15.4%) continued to have seizures despite trials
of several antiepileptic medications, although four of these drug-
refractory patients achieved a 25–50% reduction in seizure
frequency. None of the six patients with refractory epilepsy
received any other modality of treatment including ketogenic diet,
vagal nerve stimulation or epilepsy surgery.
The follow-up period at our clinic ranged from 6 months to 5
years. Thirteen patients (33.3%) were seizure-free for at least two
years. Withdrawal of antiepileptic treatment was successful in ﬁve
of these patients (5/13, 38.5%), while seizures recurred during dose
tapering in the other eight (61.5%) (Table 2).
The most common antiepileptic medications used as mono-
therapy were carbamazepine (10/39, 25.6%) and valproic acid (18/
39, 46.1%).
Results of neurological examinations were normal in 37
patients (95%). The two patients exhibiting neurological deﬁcits
were brothers (family 16 in Fig. 1). One of them was born
prematurely with diplegic cerebral palsy and had partial complex
epilepsy. The other brother had West syndrome, microcephaly, and
spasticity. The parents are paternal parallel ﬁrst cousins, and they
have a paternal uncle with consanguineous parents who is also
reported to have developmental delay. The condition in this family
may represent an X-linked or autosomal recessive syndrome.
Brain MRI showed no abnormalities in all probands except in
the male patient with diplegic cerebral palsy in family 16, who
showed periventricular white matter changes.
Before the onset of epilepsy, development/school performance
was reported to be normal in 33 patients (84.6%) and abnormal in 6
patients (15.4%). After the onset of epilepsy, global developmental
delay or poor school performance was seen in an additional ﬁve
patients (12.8%).
4.1. Family history of epilepsy in the 31 families (Fig. 1)
Consanguinity was reported among parents in 19 of the 31
families (61.3%). Among the 31 nuclear families included in this
study, 22 had two or three affected children. In nine families (29%)
the father of the proband had epilepsy, while in three families
(9.7%) the mother had epilepsy. The rate of epilepsy was similar in
children of mothers with epilepsy (33.3%) and children of fathers
with epilepsy (34.2%) (Fig. 1). In addition to a positive history of
epilepsy in siblings or parents, some families had a positive family
history of epilepsy in other relatives, including aunts in two
families (6.5%), uncles in four families (13%), and cousins in seven
families (22.6%). In families where one of the parents had epilepsy,
the total number of children ranged from 2 to 7 (average of 4)
compared to 2–11 (average of 5) among the 22 families in which
neither parent was epileptic. In the 9 families with one epileptic
parent, 17/50 offspring (34%) were also diagnosed with epilepsy. In
the 22 families with no epileptic parent, 41/99 offspring (42.4%)
were epileptic (Fig. 1).
Genetic studies were not performed at the time of study due to
technical and ﬁnancial constraints. The application of exome
sequencing in clinical practice is recent, but could be envisaged for
some families in this study, possibly on research basis, speciﬁcally
those with possible autosomal recessive inheritance. Ascertain-
ment of the modes of inheritance were deduced from pedigree
analysis (Fig. 1) and pointed to a probable autosomal dominant
Table 2
Description of seizures, responses to treatment (antiepileptic drug), EEG ﬁndings, and the probable modes of inheritance in 31 families with familial epilepsy.
Family number
as in Fig. 1
Age of onset, clinical description, response to treatment
(antiepileptic drug), and follow-up period
Type of seizures/epilepsy
syndrome
EEG characteristics Development before/
after epilepsy onset
Probable mode of
inheritance
Family 1 Onset at 5 years Partial complex/unclassiﬁed Focal spikes Normal/poor school
performance
XR
1-boy Staring, eye deviation, then secondary GTC
2-boy Last visit: two years with no seizures (1), plans to taper
treatment
Onset at 9 years GTC/unclassiﬁed Normal Normal/poor school
performance
GTC
Last visit: three years with no seizures (1), plans to taper
treatment
Family 2 AD with reduced
penetrance1-boy Onset at 10.5 years Absence/absence epilepsy Generalized Normal/normal
Staring 3Hz spikes Normal/normal
2-boy Last visit: 17 months with no seizures (2) Generalized
3-girl Onset at 12 years 3Hz spikes
Last visit: two years with no seizures (2), plans to taper
treatment
Absence/absence epilepsy Generalized
Onset at 15 years 3Hz spikes
Staring
Last visit: 10 months with no seizures (2) Absence/absence epilepsy Normal/normal
Family 3 AD with reduced
penetrance1-girl Onset at 11 years Absence and partial complex Generalized Normal/normal
Staring for a few seconds and attacks of prolonged staring
lasting a few minutes
3Hz spikes and focal
temporal
2-girl Last visit: 6 months with no seizures (2) Absence and partial complex Generalized 3Hz spikes
and focal temporal
Normal/normal
Onset at 10 years
Staring for few seconds and attacks of prolonged stare lasting a
few minutes
Last visit:7 months with no seizures (2)
Family 4 AD
1-boy Onset at 12 years GTC/unclassiﬁed Normal Normal/normal
Up rolling of eyes +GTC
Last visit: 7 months with no seizures(2)
Family 5 AR
1-girl Onset at 14 years Absence/absence epilepsy Generalized Normal/normal
2-boy Staring with GTC 3Hz spikes
Last visit: 3.5 years with no seizures (2 +3), plans to taper
treatment
Onset at 4 years Generalized
Staring 3Hz spikes Normal/normal
Received treatment for 2 years then recurrence during tapering.
Treatment restarted
Absence/absence epilepsy
Last visit: 1.5 years with no seizures (2)
Family 6 ?
1-boy Onset at 11 years Partial complex/unclassiﬁed Normal Normal/normal
Awakens from sleep dizzy and afraid, mouth deviation to one
side
Clonic movement of upper and lower limbs, then vomiting
Received treatment for 2 years then recurrence during tapering.
Treatment restarted
Last visit: 2 years with no seizures (1), plans to taper treatment
again
Family 7 AD
1-boy Onset at 2.5 years Partial complex Temporal epileptic activity Normal/normal
Staring, pallor, then GTC /unclassiﬁed
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Received treatment for 2 years with recurrence. Treatment
restarted for another 2 years. Second recurrence during
tapering. Treatment restarted
Last visit: 4 months with no seizures (1)
Family 8 ?
1-girl Onset at 7 years Absence/absence epilepsy Generalized Normal/normal
Staring 3Hz spikes
Last visit: 2 years with no seizures (2), plans to taper treatment
Family 9 AR
1-girl Onset at 6 years Partial complex Normal Normal/normal
Staring, left clonic movement of upper limb /unclassiﬁed
2-girl Received treatment (1) for 2 years then tapering
Last visit: no seizures at last follow-up
Onset at 5.5 years Partial complex Normal
Staring /unclassiﬁed Normal/normal
Received treatment for 2 years with recurrence during tapering.
Treatment restarted for another 2 years with another
recurrence during tapering. Treatment restarted again (1)
Last visit: no seizures for the last one year
Family 10 AD
1-boy Onset at 2.5 years Myoclonic/unclassiﬁed Generalized polyspikes Delayed/delayed
Myoclonic jerk with drop attacks
Uncontrolled seizures in the ﬁrst 3 years of life
Last visit: controlled for the last 4 years (2)
Family 11 AD with reduced
penetrance1-boy Onset at 7 months Partial complex/unclassiﬁed Normal Normal/delayed
Deviation of eyes to one side, clonic movements of upper and
lower limbs, frequent falls
Last visit: 10 months on polytherapy (1 +2+4), still
uncontrolled seizures
Family 12 ?
1-girl Onset at 10 years Partial complex Focal temporoparietal
epileptic activity
Normal/normal
Staring /unclassiﬁed
Received treatment for 2 years then treatment tapered (1), lost
during follow-up
Family 13 ?
1-boy Onset at 6 years Partial complex Focal spikes in
temporoparietal regions
Normal/normal
Uprolling of eyes, stares, drop attacks more than 10 times/day /unclassiﬁed
Received treatment for 2 years then recurrence during tapering.
Treatment restarted (1 +5)
Last visit: 20 months with no seizures
Family 14 ?
1-girl Onset at 10 years GTC/unclassiﬁed Normal Normal/delayed
Decrease tone, cyanosis, tonic contraction of upper and lower
limbs
Last visit: 12monthswith no seizures (1+2), lost during follow-
up
Family 15 AR
1-boy Onset at 16 years Simple focal with secondary
generalization
Normal Normal/normal
2-girl Awakens from sleep, eye and mouth deviation, then GTC /unclassiﬁed Generalized
Received treatment for 2 years then tapered (2)
Last visit: off treatment with no seizures for the past year
Onset at 9.5 years Absence/absence epilepsy 3Hz spikes Normal/normal
Awakens from sleep, up rolling of eyes, then GTC. Patient later
developed absence seizures
Received treatment for 2 years then recurrence during tapering.
Treatment restarted (3)
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Table 2 (Continued )
Family number
as in Fig. 1
Age of onset, clinical description, response to treatment
(antiepileptic drug), and follow-up period
Type of seizures/epilepsy
syndrome
EEG characteristics Development before/
after epilepsy onset
Probable mode of
inheritance
Last visit: 21 months with no seizures
Family 16 ?
1-boy Onset at 6.5 months Spasms/West syndrome Hypsarrhythmia Delayed/delayed
2-boy Spasms in series
Last visit: still on treatment (2+5+6), uncontrolled for the last
3.5 years
Onset at 7 months Partial complex/unclassiﬁed Focal spikes Delayed/delayed
Staring, eye myoclonous, focal right side seizures
Uncontrolled seizures in the ﬁrst three years of life (2 +3+4),
then seizures stopped. At 5 years, the treatment was tapered
Last visit: off treatment with no seizures for the past year
Family 17 AD with reduced
penetrance1-boy Onset at one month GTC/unclassiﬁed normal Normal/normal
GTC
Last visit: controlled for the past 6 months (1) then lost during
follow-up
Family 18 AD
1-girl Onset at 5.5 years Generalized/unclassiﬁed Generalized spikes Normal/school
difﬁculties
GTC followed by vomiting in a series over 15min
Last visit: uncontrolled seizures for the past 1.5 years (1+2)
Family 19 Onset at 9 years Generalized/unclassiﬁed Generalized spikes Normal/normal AD with reduced
penetrance
1-girl Up rolling of eyes with loss of consciousness, followed by
vomiting
Last visit: only two seizures over past two years, parents
withdrew patient from treatment (2), lost during follow-up
Family 20 AR
1-girl Onset at 9 years GTC/unclassiﬁed Generalized spikes Normal/normal
GTC
Received treatment for 2 years, recurrence during tapering.
Treatment restarted
Last visit: on treatment (2) with no seizures for the past 15
months
Family 21 AD
1-girl Onset at 2 years Generalized/unclassiﬁed Generalized spikes Normal/normal
Pallor, sweating, and loss of consciousness
Last visit: 1.5 years with no seizures (2)
Family 22 ?
1-boy Onset at 12 years Partial complex/unclassiﬁed Focal spikes in
temporoparietal regions
Normal/normal
Dizzy and change in level of consciousness
Last visit: 4 months with no seizures (2)
Family 23 ?
1-girl Onset at 6 months GTC/unclassiﬁed Generalized spikes Normal/school difﬁculty
GTC followed by vomiting
Last visit: still having seizures everymonth at the age of 8 years
(2)
Family 24 AD with reduced
penetrance1-boy Onset at 5.5 years Partial complex/unclassiﬁed Generalized spikes Normal/normal
Awakens from sleep, afraid, abnormal behavior for 2min
Last visit: 2 years with no seizures, plans to taper treatment (2)
Family 25 ?
1-boy Onset at 4 months GTC/unclassiﬁed Generalized spikes Delayed/delayed
GTC upon awakening
Last visit: still having uncontrolled seizures at the age of 15
years on polytherapy (1 +7)
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Family 26 ?
1-girl Onset at 4 months GTC/unclassiﬁed normal Normal/normal
GTC (only during sleep)
Last visit: 7 months on polytherapy(2+4+7), uncontrolled
Family 27 AD with reduced
penetrance1-boy Onset at 10 years GTC/unclassiﬁed Generalized spikes Normal/poor school
performance
GTC only during sleep
Last visit: 7 months on treatment (1)with no seizures
Family 28 AR
1-girl Onset at 8.5 years Absence/absence epilepsy Generalized spikes
3 cycles/s
Poor school performance/
poor school performance
Absence
Last visit: 20 months with no seizures(2)
Family 29 AD
1-boy Onset at one month Partial complex/unclassiﬁed Focal slow waves Normal/normal
Seizures only at the beginning of sleep. Tonic contraction of
right upper limb, chewing movements in the mouth, and
change in the level of consciousness
Presented at 6 years of age with seizures every 6 months
Last visit: 2 years with no seizures(2), plans to taper treatment
Family 30 AR
1-girl Onset at one month GTC/unclassiﬁed Normal Delayed/delayed
GTC
Presented at the age of 5 years with daily seizures
Last visit: 4 months with no seizures(1 +3+6)
Family 31 AD with reduced
penetrance1-boy Onset at 10 years Partial complex/unclassiﬁed Focal temporal spikes Normal/poor school
performance
Feels dizzy, falls, GTC
Received treatment for 2 years then recurrence during tapering.
Restarted treatment for another 2 years, then another
recurrence upon tapering. Treatment restarted again (1)
Last visit: controlled on treatment for the last one year
AD, autosomal dominant; AR, autosomal recessive; XR, X-linked recessive; GTC, generalized tonic–clonic seizures. Antiepiletic drugs: (1) carbamazepine, (2) valproic acid, (3) lamotragine, (4) levetaricitam, (5) topiramate, (6)
clonazepam, (7) phenobarbital.
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A. Masri, H. Hamamy / Seizure 22 (2013) 443–451450(AD) inheritance with or without reduced penetrance in 13
families (41.9%), a probable autosomal recessive (AR) inheritance
in 6 families (19.4%), and an X-linked recessive inheritance (XR) in
one family. In the remaining 11 families, pedigree analysis was
inconclusive or suggested more than one possible mode of
inheritance. For example it was difﬁcult to decide on whether
the mode of inheritance is XR or AR where only male offspring are
affected and parents are consanguineous. For some families, such
as for example in family 6 where there are more than one affected
offspring and the parents are not affected and not consanguineous,
compound heterozygosity cannot be excluded.
5. Discussion
This study presents the clinical and inheritance proﬁles of 39
Jordanian children belonging to 31 families with familial epilepsy
having at least one ﬁrst degree relative affected by epilepsy. Among
the 31 sibships, the majority of parents (61.3%) were consanguin-
eous. Previous studies from Jordan proved consanguinity to be a
major risk factor for neonatal and infantile epilepsy.8,9 Generalized
epilepsies were more common than partial epilepsies. Ascertain-
ment of the modes of inheritance deduced from pedigree analysis
pointed to a probable autosomal dominant (AD) inheritance with
or without reduced penetrance in 13 families, a probable
autosomal recessive (AR) inheritance in 6 families, an X-linked
recessive inheritance (XR) in one family and could not be
determined in 11 families.
The age of seizure onset in our patients ranged from one month
to 16 years. Early onset may increase the risk of these patients also
producing epileptic children. Children of epileptic parents with
seizure onset before age 20 years carry a 2.3–6% risk of epilepsy,
while onset after age 20 years confers only a 1–3.6% risk of
epilepsy in the offspring.15 In contrast, there is no increased risk of
epilepsy in the offspring of parents with epilepsy onset after age
35 years.16 It would be interesting to follow the patients in this
study after their marriage and study the risk of epilepsy in their
offspring.
Generalized epilepsies were more common than partial
epilepsies. The variety of different clinical forms of seizures
described in these patients and our inability to deﬁnitively
classify many patients suggests that there may be more distinct
idiopathic epilepsies in our population than reported here or
described in the literature (Table 2 presents descriptions of
seizures in each patient).
Most of the patients (74.4%) required only monotherapy, and
seizure control was acceptable in most cases (84.6%). Furthermore,
most patients exhibited no signs of developmental delay or
neurological deﬁcits (aside from seizures), indicating that the
familial epilepsies described in this study population were
relatively benign. Six patients (15.4%) were drug refractory, and
the majority of these patients had onset in the ﬁrst year of life. All
six exhibited developmental delay or poor school performance.
Thus, early onset and developmental delay may predict poor
outcome in response to anticonvulsant treatment for control of
seizures.
Although most cases were well controlled, the recurrence rate
after treatment withdrawal was relatively high (61.5%), indicating
that many of these epilepsy cases will persist into adolescence and
adulthood.
The rate of consanguinity among parents of affected in the
nuclear families was 61.3%. The rate of consanguinity in Jordan,
including marriages between second cousins and closer relatives,
was reported to be around 38%.2 The ﬁndings of a more recent
study in Amman revealed a drop in the rate of ﬁrst-cousin
marriages from 28.5% during the period 1950–1979 to 19.5% for
marriages after 1980.1 The higher consanguinity rate amongparents of probands than among the general population (61.3% vs.
around 20–30% at present) suggests that some cases of epilepsy in
this study may follow an autosomal recessive mode of inheritance
(Fig. 1). However, it is also possible that the higher rate of
consanguineous marriage may reﬂect negative attitudes toward
epileptic patients in Jordan,17 making it more convenient for
members of families with chronic or stigmatizing diseases such as
epilepsy to contract intrafamilial unions.
Few studies from highly consanguineous populations discussed
familial epilepsy and the role of consanguinity18–20; their results
were dependent on the methods used and the inclusion criteria. In
Turkey, 9.5% of 3098 epileptic patients had ﬁrst or second degree
relatives affected with epilepsy, and a positive family history of
consanguinity was reported in around 19% of the familial cases.18
Saadeldin et al. studied Saudi patients with benign familial and non
familial infantile seizures and reported the existence of this
epileptic syndrome for the ﬁrst time in the Arab population.19
Similarly, Abouda et al. reported a familial form of typical
childhood absence epilepsy in ﬁve Tunisian consanguineous
families and suggested an autosmal recessive mode of inheritance
in these families.20 Unlike the latter 2 studies which focused on
speciﬁc epileptic syndromes with variable age groups, our study
included all types of seizures and focused on children below 18
years of age.
In these 31 families, 38.5% of all offspring were epileptic. This
percentage is higher than expected for autosomal recessive
inheritance (25%) and lower than expected for autosomal
dominant inheritance (50%). This suggests that autosomal
recessive inheritance is more probable in some families, while
autosomal dominant inheritance with or without reduced
penetrance is more probable in others. An interesting ﬁnding is
that among the 9 families in which one parent was epileptic, 34%
of the offspring were also affected, while among the 22 families
with no affected parent, 41% of offspring were epileptic. This
ﬁnding suggests that these 22 families may harbor an autosomal
dominant candidate gene that has reduced penetrance. Applica-
tion of high-throughput sequencing and exome sequencing in
these families could reveal causative dominant or recessive genes
associated with epilepsy.21
The inclusion criteria selected for a high rate of affected
relatives. The overall risk to family members of individuals with
epilepsy is low, though higher than in the general population.
More than 90% of individuals with epilepsy have no affected
relatives, and most parents with epilepsy have no children with
epilepsy.15 Results from previous studies reported risks ranging
from 2.4% to 4.6% for offspring of parents with any kind of
epilepsy.12 A maternal effect has been described, although the
mechanism is still not fully understood.22 Mothers with epilepsy
have higher rates of affected offspring (2.8–8.7%) compared to
fathers with epilepsy (1.0–3.6%).22 In our case series, however,
the rate of epilepsy was similar in children of mothers with
epilepsy (33.3%) and children of fathers with epilepsy (34.2%)
(Fig. 1). Around 29% of the families had a father with epilepsy,
while only around 10% had a mother with epilepsy. The presence
of a higher percentage of affected fathers in our series might be
related to cultural issues; females with chronic diseases such as
epilepsy may be less likely to marry and have children due to the
stigma of the disease.
Married couples with one epileptic partner had about the same
number of children on average (four) as couples in which neither
was epileptic (ﬁve). This ﬁnding is in contrast to previous studies
reporting that parents with epilepsy have fewer children than
parents without epilepsy.23 The benign nature of the epilepsy
syndromes in these families may account for this result.
Alternatively, any effect may be overshadowed by the general
trend for large families in Jordan.
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This retrospective study has several limitations including the
relatively small sample size and the referral and tertiary care bias.
Due to the difﬁculty in contacting the affected in the family who
were not seen in the clinic resulted in the lack of details of the
types, and management protocols of epilepsy in these affected
family members. The study also lacks formal neuropsychological
assessment and genetic analysis because of ﬁnancial and technical
impediments.
6. Conclusions
While this retrospective study has several limitations, it is the
ﬁrst report on familial epilepsy involving ﬁrst degree relatives from
a country with a high rate of consanguineous marriage. Several
important conclusions can be drawn from this study. First, Seizures
in children who had parents with epilepsy were generally well
controlled, but tapering antiepileptic treatment may be difﬁcult.
Second, the mode of inheritance could be autosomal dominant
with reduced penetrance or autosomal recessive. While genetic
testing including exome sequencing has not been done yet, it will
be helpful to clarify the pathogenic mechanisms of epilepsy in
these families and aid in genetic counseling. Moreover, such
genetic analyses may also reveal novel autosomal recessive genes
associated with epilepsy.
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